SciRhom: Funding, Investors & Team (Sep 2026)
SciRhom GmbH is a biotech company established in 2016 that focuses on developing new biopharmaceuticals for severe autoimmune diseases by leveraging academic research and expertise in antibody development.
SciRhom has raised $68.2M across 1 funding round on record, the most recent a Series A of $68.2M announced in Jul 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
SciRhom Company Profile and Key Stats
Latest funding round on record: Jul 2024.
SciRhom Funding Rounds
SciRhom Founders and Leadership Team
Contact details for the SciRhom team: 1 of 1 has an email address on file.
Start 14-day free trial →SciRhom Funding Compared to Other Biotechnology Startups
SciRhom's latest round of $68.2M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like SciRhom in Biotechnology and Martinsried
Companies Similar to SciRhom
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
smartbax develop novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug…
Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of…
NanoStruct is a biotechnology company that develops nanostructured sensor chips to identify bacteria and…
Tacalyx, a company originating from Max-Planck-Institute of Colloids and Interfaces in Potsdam, Germany, is…
Primogene is a biotechnology company that provides ingredient development, bioprocess manufacturing, and…
Mbiomics is a company in the field of biotechnology.
At EVANIUM, we make plant compounds like polyphenols and flavonoids more effective by improving their…
Picea Biosolutions is a biotechnology firm. Based on their core platform technology, they develop tailored…
KUPANDO is a pioneering biopharmaceutical firm that is developing TLR 4/7 agonists to boost innate immunity.…
SciRhom Funding FAQs
What does SciRhom do?
SciRhom GmbH is a biotech company established in 2016 that focuses on developing new biopharmaceuticals for severe autoimmune diseases by leveraging academic research and expertise in antibody development.
How much funding has SciRhom raised?
SciRhom has raised $68.2M across 1 round on record. The most recent is a Series A of $68.2M announced in Jul 2024.
When did SciRhom last raise funding?
SciRhom's most recent funding round on record is a Series A of $68.2M, announced in Jul 2024.
Who founded SciRhom?
FundedIQ lists Jens Ruhe (Founder) at SciRhom.
Where is SciRhom headquartered?
SciRhom is based in Martinsried, Bayern, Germany.
How many employees does SciRhom have?
SciRhom is in the 1-10 employee band.
How does SciRhom's funding compare to other Biotechnology startups?
SciRhom's latest round of $68.2M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's SciRhom Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SciRhom is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.